Next Article in Journal
Electrophysiological Studies of Cognitive Reappraisal Success and Failure in aMCI
Previous Article in Journal
Success of Hand Movement Imagination Depends on Personality Traits, Brain Asymmetry, and Degree of Handedness
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

ADGRL3, FGF1 and DRD4: Linkage and Association with Working Memory and Perceptual Organization Candidate Endophenotypes in ADHD

by
Martha L. Cervantes-Henriquez
1,2,*,†,
Johan E. Acosta-López
1,
Mostapha Ahmad
1,
Manuel Sánchez-Rojas
1,
Giomar Jiménez-Figueroa
1,
Wilmar Pineda-Alhucema
1,
Martha L. Martinez-Banfi
1,
Luz M. Noguera-Machacón
1,
Elsy Mejía-Segura
1,
Moisés De La Hoz
1,
Mauricio Arcos-Holzinger
3,
David A. Pineda
4,
Pedro J. Puentes-Rozo
5,†,
Mauricio Arcos-Burgos
3,† and
Jorge I. Vélez
2,*,†
1
Facultad de Ciencias Jurídicas y Sociales, Universidad Simón Bolívar, Barranquilla 080005, Colombia
2
Universidad del Norte, Barranquilla 081007, Colombia
3
Grupo de Investigación en Psiquiatría (GIPSI), Departamento de Psiquiatría, Instituto de Investigaciones Mxdicas, Facultad de Medicina, Universidad de Antioquia, Medellin 050010, Colombia
4
Grupo de Neuropsicología y Conducta, Universidad de San Buenaventura, Medellín 050010, Colombia
5
Grupo de Neurociencias del Caribe, Universidad del Atlántico, Barranquilla 081001, Colombia
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Submission received: 7 May 2021 / Revised: 14 June 2021 / Accepted: 21 June 2021 / Published: 26 June 2021
(This article belongs to the Section Behavioral Neuroscience)

Abstract

:
Attention deficit hyperactivity disorder (ADHD) is a highly heritable neurobehavioral disorder that affects children worldwide, with detrimental long-term consequences in affected individuals. ADHD-affected patients display visual–motor and visuospatial abilities and skills that depart from those exhibited by non-affected individuals and struggle with perceptual organization, which might partially explain impulsive responses. Endophenotypes (quantifiable or dimensional constructs that are closely related to the root cause of the disease) might provide a more powerful and objective framework for dissecting the underlying neurobiology of ADHD than that of categories offered by the syndromic classification. In here, we explore the potential presence of the linkage and association of single-nucleotide polymorphisms (SNPs), harbored in genes implicated in the etiology of ADHD (ADGRL3, DRD4, and FGF1), with cognitive endophenotypes related to working memory and perceptual organization in 113 nuclear families. These families were ascertained from a geographical area of the Caribbean coast, in the north of Colombia, where the community is characterized by its ethnic diversity and differential gene pool. We found a significant association and linkage of markers ADGRL3-rs1565902, DRD4-rs916457 and FGF1-rs2282794 to neuropsychological tasks outlining working memory and perceptual organization such as performance in the digits forward and backward, arithmetic, similarities, the completion of figures and the assembly of objects. Our results provide strong support to understand ADHD as a combination of working memory and perceptual organization deficits and highlight the importance of the genetic background shaping the neurobiology, clinical complexity, and physiopathology of ADHD. Further, this study supplements new information regarding an ethnically diverse community with a vast African American contribution, where ADHD studies are scarce.

1. Introduction

Attention deficit hyperactivity disorder (ADHD) is a neurobehavioral disorder that affects 8 to 18% of the population [1,2,3,4]. Inattention, hyperactivity and impulsivity symptoms are more frequent in ADHD individuals than in children and adolescents of the same age and developmental level, with ADHD symptoms persisting into adulthood in 40–50% of cases [5]. Heritability estimates indicate that the genetic factors explain up to 75–95% of symptoms’ variability of the disorder [6,7].
Endophenotypes are quantifiable or dimensional constructs that are closely related to the final physiopathological cause of the disease [8,9,10,11]. Endophenotypes, or the extreme presentation of these traits: (i) occur more frequently in individuals with the disease, (ii) co-segregate in families, and/or (iii) manifest in individuals with variable expressivity and/or variable penetrance depending upon whether the disease is present [10,11]. Thus, endophenotypes are seen as a proxy to the actual phenotype as they connect behavioral symptoms with the well-understood illness associated with known genetic causes [8,12,13,14,15]. In ADHD, endophenotypes have allowed the definition of potential neurobiological markers for detecting ADHD susceptibility loci [10,13,16,17,18]. Due to their continuous nature, endophenotypes are more powerful, statistically speaking, to uncover genetic variants associated with the disease and, therefore, the sample size required for its detection is smaller if compared to the sample size needed when dealing with binary traits [18,19].
ADHD individuals lack visual–motor skills and visuospatial ability [16,20] and show alterations in the perception and processing of temporal information [21,22,23], difficulties in scheduling behaviors and tolerating waiting [24], deficiencies in perceptual organization, and deficiencies in the measurement of sensory–motor function, stimulus processing (i.e., auditory, visual, tactile and kinesthetic), stimulus–response association, time to produce correct responses, speed–efficiency balance, decision making and response programming [25], which lead to impulsive responses [26,27]. Furthermore, ADHD-affected individuals show a myriad of symptoms in different dimensions, and evident difficulties in sensory modalities and perceptual organization [28], working memory [29] and attention use in tasks based on visuospatial aspects [30,31,32,33], which are important constructs for spatial and verbal processing in higher order tasks [34] and are crucial for the identification and recognition of objects and surfaces in the environment [35]. Such difficulties coexist with cognitive and behavioral aspects [36].
Changes in pupil size and diameter may reflect increased mental and/or cognitive effort [37,38,39], and this is one of the mechanisms that reveals an underlying neuronal action [40]. In ADHD, pupil size is associated with possible alterations at the visual perception level [41,42,43] and related to attentional and behavioral processes (i.e., reaction times) as well as to the perceptive identification through eye movements and duration of fixation [44,45]. Thus, deficits in sensory activation ability may explain some of the central deficits found in ADHD [46,47,48].
We recently identified ADHD cognitive endophenotypes related to working memory and perceptual organization in nuclear families segregating ADHD [49] in a Caribbean community with one of the largest African admixtures in Colombia and South America [50,51,52]. Now, in this study, we explore whether genetic variation is a major component underpinning the biological basis of these traits. Single nucleotide polymorphisms (SNPs) harbored in genes previously associated with ADHD in our family-based cohort were tested for linkage and association with endophenotypes of working memory and perceptual organization. Our overarching hypothesis is that genetic variation implicated in conferring susceptibility to ADHD is also associated with working memory and perceptual organization, which in turn may help to better understand the underlying mechanisms shaping the complexity of multisensorial alterations in ADHD.

2. Materials and Methods

2.1. Subjects

We recruited and clinically characterized 386 individuals (218 (56.5%) males, 168 (43.5%) females; 224 (58%) with ADHD, 162 (42%) controls) from 113 nuclear families with at least one ADHD proband. A total of 120 (31.1%) were children (6–11 years), 34 (8.8%) were adolescents (12–17 years) and 232 (60.1%) were adults (>17 years). All individuals were born in and inhabit the metropolitan area of Barranquilla, Colombia. No children or adults were treated with medication for ADHD at initial assessment. The full neurological, neuropsychological and psychological assessment, as well as demographic information, has been reported elsewhere [49,52,53]. Briefly, 408 individuals belonging to 120 nuclear families and ascertained from probands affected by ADHD initially participated in our clinical and genetic studies of ADHD. ADHD diagnosis was assessed in all individuals using behavioral [54,55,56] and psychopathological interviews, which include the structured Diagnostic Interview for Children and Adults (DICA) version IV [57]. This interview (1) considers the A criterion of the DSM-IV, (2) utilizes a systematic approach to collect clinical information about ADHD symptoms exhibited by an individual using a binary classification (0 = absent; 1 = present) system, and (3) has been extensively used by our group and others in genetic studies of ADHD [27,49,52,53,58,59,60]. ADHD symptom data were collected during the clinical assessment stage, where 11 schools were visited (seven of medium socio-economic stratum). Several meetings were held with teachers of children aged between 6 and 11 years old to explain the objective of the study. Teachers were asked to identify children about whom they had concerns that might affect their academic performance and/or behavior in the school environment. Parents or guardians were administered the Spanish version of the DICA-IV interview for parents (DICA-IV-P). As genetic data were not available for seven families from the original cohort, only 113 out of the 120 nuclear families were included in the present study. This study was approved by the Ethics Committee of Universidad Simón Bolívar, Barranquilla, Colombia (approval # 00032, 13 October 2011).

2.2. Endophenotypes

Based on the multidimensional clinical assessment, we recently identified that the digits forward and backward, arithmetic and similarities were candidate endophenotypes in Caribbean families segregating ADHD. These tasks have been related to the phonological loop of working memory (digit forward), central executive working memory (digit backward), and working memory episodic buffer (arithmetic and similarities) [61,62,63], which correspond to working memory components [32,64,65]. Furthermore, neuropsychological tasks such as the completion of figures and the assembly of objects, which would assess visual detail detection, spatial object orientation, and visuospatial problem-solving cognitive domains, constitute endophenotypes of working memory and perceptual organization based on a hierarchical model of functions [49,66,67,68] (Table 1). A machine learning algorithm including these endophenotypes predicts ADHD diagnosis with 81.5% accuracy (95% confidence interval (CI) = 77.5–85.0) [49].

2.3. DNA Extraction and Genotyping

DNA extraction and genotyping were performed as described elsewhere [52]. Briefly, genomic DNA was isolated from blood samples using the MasterPure® DNA Purification Kit (Epicentre Biotechnologies, Chicago, IL, USA) according to the manufacturer’s protocol. DNA concentrations were measured using a NanoDrop™ 2000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). Genotyping was performed at the University of Arizona Genetics Core using the multiplex Sequenom® Technology on Agena Bioscience’s MassARRAY® MALDI-TOF instrument. A total of 26 intronic SNPs were initially genotyped in our family-based cohort (Supplementary Materials Table S1) [52].
Allele and genotype frequencies were estimated using maximum likelihood. Mendelian errors and missing genotypes, common features in SNP-based genotyping, were detected and subsequently corrected with the methods available in Golden Helix’s® SNP variation suite (SVS) 8.4.0 (Golden Helix, Inc. Bozeman, MT, USA; https://www.goldenhelix.com/, accessed on 19 December 2019). Golden Helix’s SVS is an integrated collection of analytic tools for managing, analyzing, and visualizing multifaceted genomic and phenotypic data. In this study, only SNPs harbored in genes previously reported to confer susceptibility to ADHD in our sample were selected to explore their association with ADHD endophenotypes of working memory and perceptual organization.

2.4. Family-Based Association Analysis

We used the family-based association test (FBAT) to assess linkage and association of SNPs with perceptual organization endophenotypes in our cohort, which includes complex family structures with multiple affected individuals and, in some cases, several probands, which introduces complex patterns of ascertainment. The FBAT provides a unified framework to generalize the transmission disequilibrium test [69,70] and accounts for different genetic models, sampling of family-based ascertainment designs, disease phenotypes, missing parents, and different null hypotheses [70]. Furthermore, FBAT screening methods are minimally affected by non-causal SNPs, and are robust against effects of population stratification and admixture, since the final decision is based on the FBAT statistic [71].
We used the implementation of the FBAT provided in the Pedigree-based association test (PBAT) module of Golden Helix’s SVS 8.4.0. The FBAT allows the testing of a combination of phenotypes (as a group) and genotypes that have the highest power by those predicted from the parents’ genotypes. As age and gender are known to impact ADHD susceptibility, both variables were included as ADHD covariates under the hypothesis of no linkage and no association. Adding these covariates increases the FBAT power substantially [72,73]. Additive, dominant, recessive and heterozygous advantage models of inheritance were explored to assess the association between SNPs and working memory and perceptual organization endophenotypes. Under an additive model, having 0, 1 or 2 copies of the major allele linearly increases/decreases the value of an endophenotype; under a dominant model, having at least one copy of the dominant allele increases/decreases the value of the endophenotype; and under a recessive model, having two copies of the minor allele increases/decreases the endophenotype versus having one or no copies. P-values from the FBAT were corrected for multiple testing using Bonferroni’s method [74,75].

3. Results

As multiple tests were applied in our genetic association analysis (i.e., five di-allelic markers, two covariates and four models of inheritance, resulting in a total of 5 × 2 × 4 = 40 tests), p-values were corrected using Bonferroni’s method. Table 2 shows the main results of the FBATs.
We found significant association and linkage of markers ADGRL3-rs1565902, DRD4-rs916457 and FGF1-rs2282794 to the performance on the arithmetic (T47), similarities (T48), figure completion (T49) and object assembly (T52) subtests after FDR correction.
Our results suggest that marker ADGRL3-rs1565902 is statistically significantly associated and linked to the performance in the arithmetic subtest under the additive model of inheritance (p = 0.014; Table 2). Similarly, we found evidence of linkage and association of marker DRD4-rs916457 with the performance in the figure completion subtest under the additive (p = 0.005) and dominant (p = 0.005) genetic models of inheritance (Table 2).
In addition, marker FGF1-rs2282794 was found to be associated with the performance in the similarities subtest under the additive (p = 0.004), dominant (p = 0.00019) and recessive (p = 0.00019) models of inheritance; with the performance in the figure under the dominant (p = 0.006) and recessive (p = 0.006) models of inheritance; and with the performance in the object assembly subtest under the heterozygous advantage model of inheritance (p = 0.005; Table 2).

4. Discussion

Genetic studies in ADHD have mainly focused on identifying associations with nuclear symptoms [76], with genes delineating visual–constructional skills at the perceptual organization level being identified in Caucasian and Asian populations [77]. In this study, we explore the association between SNPs and endophenotypes of working memory and perceptual organization [49] in 113 nuclear families from an understudied Caribbean community segregating ADHD and inhabiting the metropolitan area of Barranquilla, Colombia. The Colombian Caribbean region is the result of a racial admixture and the presence of a large African genetic component [50,51,78].
ADHD etiology is complex and strongly related to neurotransmitter pathways, i.e., dopamine [42]. Family-based and genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) in the DRD4 gene associated with ADHD [43,79,80,81,82,83,84,85]. Furthermore, genetic variants in the FGF1 [17,52] and ADGRL3 (LPHN3) [17,52,58,59,83,86,87,88,89,90,91,92,93] genes are associated with ADHD and ADHD endophenotypes. Other endophenotype-associated genes include DAT1, COMT, DBH, MAOA, DRD5, ADRA2A, GRIN2A, BDNF and TPH2 [94,95].
Here, we found that variants DRDR4-rs916457, FGF1-rs2282794 and ADGRL3-rs1565902 are associated with ADHD endophenotypes defined by the total digits, arithmetic and analogies, which evaluate working memory components [33,96], as well as incomplete figures and object assembly, which are related to perceptual organization (Table 2). In addition to allowing the identification of genes correlated with ADHD, linkage and association analyses of endophenotypes also allow the exploration of the underlying cognitive processes, such as perceptual organization [8,16,17], which is correlated with neuropsychological functioning during stimulus processing such as tracking and visual search tasks, and is widely used to examine automatic selective attention and stress [97,98].
Cortical activations differ between visual and auditory stimuli, with greater variability in the former [99]. In addition, the type of presentation seems to also influence the determination of response accuracy; these group differences suggest deficiencies in the basic timing mechanisms, such as neurophysiological resource failure, for ADHD [100]. Electrophysiological and imaging studies in ADHD show a generated alpha-lateralized modulation in the occipital and parietal cortex [101,102]. At the structural level, there is a correlation between the number of attentional failures and the volume of gray matter in the left occipital cortex [103,104]. Studies using event-related potentials indicate a significant involvement of the visual cortex in visual attention tasks [105,106,107]. Similarly, studies with functional magnetic resonance show a lower occipital activation in perceptive processes of visual attention in ADHD [108].
These deficiencies are a combination of cognitive control processes, as working memory components, and the perceptual integrative processes, among which are: visual coding, visual processing of the stimulus [109,110], sensory and eye pursuit movement, binocular tracking [111,112], perceptual attention profiles [113], perceptual variability, visual perception and representation, time of visual processing, visual–motor skills [114], resolution of visuospatial problems, self-reported deficiencies in perceptual function and abnormal perceptual experience [8,16,17,21,22,46,47,48,115,116,117,118]. Clinically abnormal perceptions affect visual memory, spatial relationships and sequential memory, suggesting specific patterns of altered visual perception [41,47,119,120]. This is mainly due to the fact that subcomponents of working memory are closely related to each other, as well as with other cognitive systems such as long-term memory (LTM), executive functions, attention and information processing speed [121]. Due to the complexity and heterogeneity of ADHD, such processes have been proposed as probable endophenotypes [122,123,124,125].
The receptor encoded by the DRD4 gene is highly expressed in several key brain regions, including the prefrontal cortex, the medial temporal lobe, the hippocampus, the amygdala, and the hypothalamus [126,127,128,129,130], which are related to autoregulation deficits and the functional and structural integrity of the primary sensorial network, and regulates the efficiency of the central dopaminergic pathway involved in the post-synaptic action of dopamine [131]. It has been shown that DRD4 modulates the surrounding response of the center off ganglion cell, favoring spatial contrast sensitivity and color vision and enhancing the trophic function, retinal cell survival, and eye growth [132]. More recently, DRD4 has been associated with the occurrence of the subject’s blink as an index of dopaminergic activity behavior [133]. Furthermore, DRD4 is involved in perception and response to perception as well as in response to sensory stimuli, attention and other higher brain functions such as planning, reward and regulation of executive functions [128,129,131].
FGF1 belongs to the FGF family, which is involved in several pathological conditions such as metabolic disorders, participates in the regulation of physiological processes such as the development, angiogenesis, adipogenesis and neurogenesis of the CNS, performs basic functions during embryonic development [134] and is involved in processes such as proliferation, adhesion, differentiation, survival, apoptosis, neuronal plasticity and cell motility [135]. FGF1 signaling is required during the formation of neural plaque because it modulates the growth and pattern of specific brain structures (i.e., dorsolateral prefrontal cortex and the anterior cingulate cortex, which is involved in some components of working memory, especially central executive and episodic buffer) [136,137,138,139]. Furthermore, FGF1 plays an important role in sensory development [137,140], specifically in the modeling of the bipotential optical vesicle [141,142,143], and improves sensory responses, especially in discrimination, comparison and location tasks [144].
ADGRL3 (previously known as LPHN3), on the other hand, is a member of the latrophilin subfamily of G-protein coupled receptors and is highly expressed in the brain, particularly in the amygdala, the caudate and pontine nucleus, and cerebellum [58,59,60,86,93,145]. ADGRL3 plays an important role in cellular adhesion and signal transduction, and is also expressed in the cornea [146] and is associated with alterations in the neuronal activities in visual tasks (i.e., Go/No-Go tasks) [147]. Latrophilins are relevant for neuronal development and brain functions [148]. Furthermore, ADGRL3 has been shown to interact with DRD4 (i.e., dysfunction and signaling in DRD4 are mediated by the action of ADGRL3 [86,149]), affecting the development of dopaminergic neurons [150].
We identified that variant ADGRL3-rs1565902 is associated with the arithmetic subtest (Table 2), which would require high mental effort to perform mental calculations and hence implicate activity of the central executive and episodic buffer of working memory. Numeric sense has been considered a non-verbal skill that involves spatial relationships between numbers at the mental level [151]. This information is represented and processed by regions of the bilateral lobes (i.e., inferior parietal lobe and precuneus), frontal–striatal and mesial temporal activation, and by the prefrontal (i.e., superior and medial frontal gyri) and inferior frontal and intraparietal sulcus [151,152,153], where ADGLR3 is expressed [89]. As calculation tasks become more complex, there is a greater activation of the frontal region and cortical regions that underlie magnitude processing [154,155], which are important for numerical, visual and attentional processing [156,157,158], and the representation of the semantic aspect of quantity [159], which is directly related to working memory, including visual processing, speech understanding and episodic memory [160,161]. Finding that variants within ADGRL3 are associated with ADHD cognitive endophenotypes may help to determine the nature of the cognitive alterations interacting with the genetic risk of ADHD [16,17,49,162].
We found that marker FGF1-rs2282794 is associated with the object assembly and analogies endophenotype, which is correlated to working memory components that have connections with perceptual aspects established as dual information processing (Table 2) [163]. FGF1, involved in the development of the eye and the demarcation of the neural retina, the pigmented epithelium [143], lens formation [143,164] and axonal growth [142,165] as well as in neuronal protection and survival [166,167], deserves greater attention due to the interruptions in the frontoparietal, dorsal attentional, motor and visual networks [168], which may lead to significant reductions in the volume of gray matter in the early visual cortex and specialized cortical areas for the identification of visual stimuli based on color, orientation and other aspects of shape [169,170,171]. In addition, some studies report the deactivation of the parietal and occipital regions during spatial tasks [109,172]. Such deviations are directly related to difficulties in visual–spatial intelligence, where the ability to analyze and synthesize abstract stimuli and establish relationships between parts and non-verbal reasoning, evident in the object assembly tests [173] as well as in the grouping of information for the formation of concepts, is a voluntary propositional process according to a series of inferential models of visual processing (i.e., analogies test) [174].
Marker DRD4-rs916457 is associated with the total digits and incomplete figures endophenotypes (Table 2) and expressed in key brain regions (Supplementary Figure S1). DRD4 is highly expressed in the fronto-subcortical system in the hypothalamus, thalamus, olfactory bulb and hippocampus, which are part of the limbic system [130], as well as in cortical regions, the frontal cortex, occipital lobes and the cerebellum [35]. An imbalance of different dopaminergic transmission modes may be related to ADHD symptomatology [175]. Variants in DRD4 are also associated with perceptual organization [176], which is related to the overlap between perception and visual memory that leads to a process of continuous perceptual alternation, where the brain must select a new interpretation in each repetition of the same stimulus by simultaneous and/or alternating action [177], suggesting a multiplicity of steps in this process occurring in hierarchically organized regions in the cortex. Thus, early visual areas register basic characteristics, and the superior areas unite them in objects and select the most relevant [178].
Despite our encouraging results, some limitations are to be acknowledged. First, the lack of pupil measurements in individuals of our cohort to determine the pupil diameter and rule out possible eye alterations that may impact perceptual organization is a limitation. Second, genotyped variants are localized in intronic regions. Although variants found to be in linkage and association give important insight into the neurobiological aspects of perceptual organization endophenotypes in our cohort, they may not necessarily be causal variants. In this sense, in silico and animal models may help to elucidate the role of such genetic variation at the protein level and how such changes may impact ADHD susceptibility, severity and long-term outcome. Third, only a few SNPs were available, which restricted the identification of potential associations in other genes of interest. This is a common problem, especially in understudied populations, such as the Caribbean community in Colombia [50,51,52].
In summary, our findings suggest that variants in DRD4, ADGLR3 and FGF1 are associated with ADHD endophenotypes related to perceptual organization and, as such, may constitute a new explanatory view of ADHD considering that people with the disorder present alterations in visual and speech perception, which are also determinants of symptom severity [116]. We also confirm the role of genes highly expressed in key regions of the brain related to attention and neurocognitive activity in affecting the metabolism of the neuronal circuits involved in ADHD in this Caribbean community. To the best of our knowledge, only a few studies have shown the association of marker FGF1-rs2282794 with ADHD and ADHD endophenotypes [17,52]. Finding this marker is also associated with endophenotypes of working memory and perceptual organization in our cohort (Table 2) gives supporting evidence about the role of FGF1 as a potential candidate for ADHD. In neurosciences and neuropsychology, our results could contribute to the design, refinement and establishment of a theoretical construct of perceptual organization as a cognitive dimension in ADHD, supported by neurobiological evidence [179]. However, we are aware that replication in a population with different genetic backgrounds is needed. Future studies could greatly benefit from the use of high-throughput genotyping/sequencing for the identification of putative causal variants underpinning perceptual organization in ADHD, leading to the identification of genetic profiles better responding to specific ADHD treatments and the development of translational medicine approaches [180,181]. Furthermore, these variants could also be used for developing predictive models, based on machine learning and artificial intelligence [182,183,184], for ADHD diagnosis and the identification of severe ADHD cases [97,115,120,185] in the clinical setting.

Supplementary Materials

The following are available online at https://0-www-mdpi-com.brum.beds.ac.uk/article/10.3390/brainsci11070854/s1, Figure S1: Multi-tissue eQTL comparison for DRD4-rs916457 according to GTExPortal (https://gtexportal.org/home/snp/rs916457); Table S1: Single nucleotide polymorphisms (SNPs) genotyped in 386 individuals belonging to 113 nuclear families from Barranquilla, Colombia.

Author Contributions

Conceptualization: M.A.-B., J.I.V.; methodology: M.A.-B., J.I.V.; validation: M.L.C.-H., J.E.A.-L., M.A., G.J.-F., W.P.-A., M.L.M.-B., L.M.N.-M., E.M.-S., M.D.L.H., D.A.P., P.J.P.-R., M.A.-B., J.I.V.; formal analysis: M.L.C.-H., M.A.-B., J.I.V.; investigation: M.L.C.-H., J.E.A.-L., G.J.-F., W.P.-A., M.L.M.-B., L.M.N.-M., E.M.-S., M.D.L.H., M.S.-R., P.J.P.-R.; resources: J.E.A.-L., M.S.-R., P.J.P.-R., J.I.V.; data curation: M.L.C.-H., J.I.V.; writing—original draft preparation: M.L.C.-H., M.A.-H., M.A.-B., J.I.V.; writing—review and editing: M.L.C.-H., J.E.A.-L., M.A., M.A.-H., D.A.P., P.J.P.-R., M.A.-B., J.I.V.; visualization: M.L.C.-H., M.A.-B., J.I.V.; supervision: M.A.-B., J.I.V.; project administration: J.I.V.; funding acquisition: M.L.C.-H., J.E.A.-L., P.J.P.-R., J.I.V. All authors have read and agreed to the published version of the manuscript.

Funding

This study was financed by COLCIENCIAS, project “Fenotipos Complejos y Endofenotipos del Trastorno por Déficit de Atención e Hiperactividad y su Asociación con Genes Mayores y de Susceptibilidad”, grant 1253-5453-1644, contract RC 384-2011, conferred to Grupo de Neurociencias del Caribe, Universidad Simón Bolívar, Barranquilla. M.L.C.-H., J.E.A.-L. and J.I.V. were partially supported by research grant FOFICO 32101 PE0031 from Universidad del Norte, Barranquilla, Colombia. The APC was funded by Universidad Simón Bolívar, Barranquilla, Colombia.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of Universidad Simón Bolívar, Barranquilla, Colombia (approval # 00032, 13 October 2011).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Acknowledgments

We express our highest appreciation to all idividuals enrolled in this study. M.L.C.-H. is a doctoral student at Universidad del Norte, Barranquilla, Colombia. Some of this work is to be presented in partial fulfilment of the requirements for the PhD degree. M.L.C.-H., P.J.P.-R., M.A.-B. and J.I.V. have full access to all the data in the study and are responsible for submitting this work for publication.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Cardo, E.; Servera-Barcelo, M. The prevalence of attention deficit hyperactivity disorder. Rev. Neurol. 2005, 40 (Suppl. 1), S11–S15. [Google Scholar]
  2. Biederman, J. Attention-deficit/hyperactivity disorder: A selective overview. Biol. Psychiatry 2005, 57, 1215–1220. [Google Scholar] [CrossRef] [PubMed]
  3. Cornejo Ochoa, J.W.; Osío, O.; Sánchez, Y.; Carrizosa, J.; Sánchez, G.; Grisales, H.; Castillo-Parra, H.; Holguín, J. Prevalencia del trastorno por déficit de atención- hiperactividad en niños y adolescentes Colombianos. Rev. Neurol. 2005, 40, 716–722. [Google Scholar] [CrossRef]
  4. Van Meerbeke, A.V.; Gutiérrez, C.T.; Reyes, R.G.; Pinilla, M.I. Prevalencia de trastorno por déficit de atención con hiperactividad en estudiantes de escuelas de Bogotá, Colombia. Acta Neurol. Colomb. 2008, 24, 6–12. [Google Scholar]
  5. DSM-IV. In Masson; Barcelona: 2002. Manual Diagnóstico y Estadístico de los Trastornos Mentales, Texto Revisado; American Psychiatric Association: Washington, DC, USA, 2015.
  6. Thapar, A.; Holmes, J.; Poulton, K.; Harrington, R. Genetic basis of attention deficit and hyperactivity. Br. J. Psychiatry 1999, 174, 105–111. [Google Scholar] [CrossRef]
  7. Thapar, A.; O’Donovan, M.; Owen, M.J. The genetics of attention deficit hyperactivity disorder. Hum. Mol. Genet. 2005, 14 (Suppl. 2), R275–R282. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Castellanos, F.X.; Tannock, R. Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes. Nat. Rev. Neurosci. 2002, 3, 617–628. [Google Scholar] [CrossRef]
  9. Gottesman, I.I.; Gould, T.D. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am. J. Psychiatry 2003, 160, 636–645. [Google Scholar] [CrossRef]
  10. Flint, J.; Munafò, M.R. The endophenotype concept in psychiatric genetics. Psychol. Med. 2007, 37, 163–180. [Google Scholar] [CrossRef]
  11. Walters, J.T.R.; Owen, M.J. Endophenotypes in psychiatric genetics. Mol. Psychiatry 2007, 12, 886–890. [Google Scholar] [CrossRef]
  12. Cannon, T.D.; Gasperoni, T.L.; van Erp, T.G.; Rosso, I.M. Quantitative neural indicators of liability to schizophrenia: Implications for molecular genetic studies. Am. J. Med. Genet. 2001, 105, 16–19. [Google Scholar] [CrossRef]
  13. Goos, L.M.; Crosbie, J.; Payne, S.; Schachar, R. Validation and extension of the endophenotype model in ADHD patterns of inheritance in a family study of inhibitory control. Am. J. Psychiatry 2009, 166, 711–717. [Google Scholar] [CrossRef] [PubMed]
  14. Naj, A.C.; Jun, G.; Reitz, C.; Kunkle, B.W.; Perry, W.; Park, Y.S.; Beecham, G.W.; Rajbhandary, R.A.; Hamilton-Nelson, K.L.; Wang, L.-S.; et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: A genome-wide association study. JAMA Neurol. 2014, 71, 1394–1404. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Gregory, M.L.; Burton, V.J.; Shapiro, B.K. Developmental Disabilities and Metabolic Disorders. In Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders; Academic Press: Cambridge, MA, USA, 2015. [Google Scholar]
  16. Pineda, D.A.; Lopera, F.; Puerta, I.C.; Trujillo-Orrego, N.; Aguirre-Acevedo, D.C.; Hincapie-Henao, L.; Arango, C.P.; Acosta, M.T.; Holzinger, S.I.; Palacio, J.D.; et al. Potential cognitive endophenotypes in multigenerational families: Segregating ADHD from a genetic isolate. Atten. Defic. Hyperact. Disord. 2011, 3, 291–299. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Mastronardi, C.A.; Pillai, E.; Pineda, D.A.; Martinez, A.F.; Lopera, F.; Velez, J.I.; Palacio, J.D.; Patel, H.; Easteal, S.; Acosta, M.T.; et al. Linkage and association analysis of ADHD endophenotypes in extended and multigenerational pedigrees from a genetic isolate. Mol. Psychiatry 2016, 21, 1434–1440. [Google Scholar] [CrossRef] [PubMed]
  18. Doyle, A.E.; Faraone, S.V.; Seidman, L.J.; Willcutt, E.G.; Nigg, J.T.; Waldman, I.D.; Pennington, B.F.; Peart, J.; Biederman, J. Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD? J. Child Psychol. Psychiatry 2005, 46, 774–803. [Google Scholar] [CrossRef]
  19. Falconer, D.S.; Mackay, T.F.C. Introduction to Quantitative Genetics, 4th ed.; Addison Wesley Longman: Harlow, UK, 1996. [Google Scholar]
  20. Saito, Y.; Nakao, K.; Sugawara, A.; Nishimura, K.; Sakamoto, M.; Morii, N.; Yamada, T.; Itoh, H.; Shiono, S.; Kuriyama, T.; et al. Atrial natriuretic polypeptide during exercise in healthy man. Acta Endocrinol. Copenh. 1987, 116, 59–65. [Google Scholar] [CrossRef]
  21. Logan, G.D.; Cowan, W.B.; Davis, K.A. On the ability to inhibit simple and choice reaction time responses: A model and a method. J. Exp. Psychol. Hum. Percept. Perform. 1984, 10, 276–291. [Google Scholar] [CrossRef]
  22. Nikolas, M.A.; Nigg, J.T. Moderators of neuropsychological mechanism in attention-deficit hyperactivity disorder. J. Abnorm. Child Psychol. 2015, 43, 271–281. [Google Scholar] [CrossRef] [Green Version]
  23. Suarez, I.; De Los Reyes Aragón, C.; Diaz, E.; Iglesias, T.; Barcelo, E.; Velez, J.I.; Casini, L. How Is Temporal Processing Affected in Children with Attention-deficit/hyperactivity Disorder? Dev. Neuropsychol. 2020, 45, 246–261. [Google Scholar] [CrossRef] [PubMed]
  24. Solanto, M.V.; Abikoff, H.; Sonuga-Barke, E.; Schachar, R.; Logan, G.D.; Wigal, T.; Hechtman, L.; Hinshaw, S.; Turkel, E. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: A supplement to the NIMH multimodal treatment study of AD/HD. J. Abnorm. Child Psychol. 2001, 29, 215–228. [Google Scholar] [CrossRef] [PubMed]
  25. Gandhi, P.H.; Gokhale, P.A.; Mehta, H.B.; Shah, C.J. A comparative study of simple auditory reaction time in blind (congenitally) and sighted subjects. Indian J. Psychol. Med. 2013, 35, 273–277. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Uebel, H.; Albrecht, B.; Asherson, P.; Borger, N.A.; Butler, L.; Chen, W.; Christiansen, H.; Heise, A.; Kuntsi, J.; Schäfer, U.; et al. Performance variability, impulsivity errors and the impact of incentives as gender-independent endophenotypes for ADHD. J. Child Psychol. Psychiatry 2010, 51, 210–218. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Jimenez-Figueroa, G.; Ardila-Duarte, C.; Pineda, D.A.; Acosta-Lopez, J.E.; Cervantes-Henriquez, M.L.; Pineda-Alhucema, W.; Cervantes-Gutiérrez, J.; Quintero-Ibarra, M.; Sánchez-Rojas, M.; Vélez, J.I.; et al. Prepotent response inhibition and reaction times in children with attention deficit/hyperactivity disorder from a Caribbean community. Atten. Defic. Hyperact. Disord. 2017, 9, 199–211. [Google Scholar] [CrossRef] [PubMed]
  28. Panagiotidi, M.; Overton, P.G.; Stafford, T. The relationship between ADHD traits and sensory sensitivity in the general population. Compr. Psychiatry 2018, 80, 179–185. [Google Scholar] [CrossRef]
  29. Liu, Z.-X.; Glizer, D.; Tannock, R.; Woltering, S. EEG alpha power during maintenance of information in working memory in adults with ADHD and its plasticity due to working memory training: A randomized controlled trial. Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol. 2016, 127, 1307–1320. [Google Scholar] [CrossRef]
  30. Cowan, N. What are the differences between long-term, short-term, and working memory? Prog. Brain Res. 2008, 169, 323–338. [Google Scholar]
  31. Cowan, N. Working Memory Capacity, Classic ed.; Psychology Press: London, UK, 2016. [Google Scholar]
  32. Baddeley, A. Working memory. Curr. Biol. 2010, 20, 136–140. [Google Scholar] [CrossRef] [Green Version]
  33. Engle, R. Role of Working Memory Capacity in Cognitive Control. Curr. Anthropol. 2010, 51 (Suppl. 1), S17–S26. [Google Scholar] [CrossRef] [Green Version]
  34. Engle, R.W.; Kane, M.J. Executive attention, working memory capacity, and a two-factor theory of cognitive control. In The Psychology of Learning and Motivation: Advances in Research and Theory; Elsevier Science: Amsterdam, The Netherlands, 2004; Volume 44, pp. 145–199. [Google Scholar]
  35. Barbot, A.; Liu, S.; Kimchi, R.; Carrasco, M. Attention enhances apparent perceptual organization. Psychon. Bull. Rev. 2018, 25, 1824–1832. [Google Scholar] [CrossRef]
  36. Koziol, L.F.; Budding, D. ADHD and sensory processing disorders: Placing the diagnostic issues in context. Appl. Neuropsychol. Child 2012, 1, 137–144. [Google Scholar] [CrossRef]
  37. Sirois, S.; Brisson, J. Pupillometry. Wiley Interdiscip. Rev. Cogn. Sci. 2014, 5, 679–692. [Google Scholar] [CrossRef] [PubMed]
  38. Van der Wel, P.; van Steenbergen, H. Pupil dilation as an index of effort in cognitive control tasks: A review. Psychon. Bull. Rev. 2018, 25, 2005–2015. [Google Scholar] [CrossRef] [PubMed]
  39. Alamia, A.; VanRullen, R.; Pasqualotto, E.; Mouraux, A.; Zenon, A. Pupil-Linked Arousal Responds to Unconscious Surprisal. J. Neurosci. 2019, 39, 5369–5376. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Papesh, M.H.; Goldinger, S.D. Pupil-BLAH-metry: Cognitive effort in speech planning reflected by pupil dilation. Atten. Percept. Psychophys. 2012, 74, 754–765. [Google Scholar] [CrossRef]
  41. Redondo, B.; Molina, R.; Cano-Rodríguez, A.; Vera, J.; García, J.A.; Muñoz-Hoyos, A.; Jiménez, R. Visual Perceptual Skills in Attention-deficit/Hyperactivity Disorder Children: The Mediating Role of Comorbidities. Optom. Vis. Sci. Off. Publ. Am. Acad. Optom. 2019, 96, 655–663. [Google Scholar] [CrossRef]
  42. Small, D.J.; Eaton, V.; Koh, W.Y.; Langlais, A.; Bergquist, I.; Mokler, D.; Prudovsky, I. Increased Locomotor Activity is Associated with Enhanced Tyrosine Hydroxylase Expression in Mice Expressing an Endothelial Cell-Specific Fibroblast Growth Factor 1 Transgene. FASEB J. 2018, 32 (Suppl. 1), 805–823. [Google Scholar] [CrossRef]
  43. Bhaduri, N.; Das, M.; Sinha, S.; Chattopadhyay, A.; Gangopadhyay, P.K.; Chaudhuri, K.; Singh, M.; Mukhopadhyay, K. Association of dopamine D4 receptor (DRD4) polymorphisms with attention deficit hyperactivity disorder in Indian population. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet. 2006, 141, 61–66. [Google Scholar] [CrossRef]
  44. Rayner, K.; Duffy, S.A. Lexical complexity and fixation times in reading: Effects of word frequency, verb complexity, and lexical ambiguity. Mem. Cognit. 1986, 14, 191–201. [Google Scholar] [CrossRef]
  45. Wainstein, G.; Rojas-Líbano, D.; Crossley, N.A.; Carrasco, X.; Aboitiz, F.; Ossandón, T. Pupil Size Tracks Attentional Performance in Attention-Deficit/Hyperactivity Disorder. Sci. Rep. 2017, 7, 8228. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Sable, J.J.; Kyle, M.R.; Knopf, K.L.; Schully, L.T.; Brooks, M.M.; Parry, K.H.; Diamond, R.E.; Flink, L.A.; Stowe, R.; Suna, E.; et al. The Sensory Gating Inventory as a potential diagnostic tool for attention-deficit hyperactivity disorder. Atten. Defic. Hyperact. Disord. 2012, 4, 141–144. [Google Scholar] [CrossRef]
  47. Micoulaud-Franchi, J.-A.; Vaillant, F.; Lopez, R.; Peri, P.; Baillif, A.; Brandejsky, L.; Steffen, M.L.; Boyer, L.; Richieri, R.; Cermolacce, M.; et al. Sensory gating in adult with attention-deficit/hyperactivity disorder: Event-evoked potential and perceptual experience reports comparisons with schizophrenia. Biol. Psychol. 2015, 107, 16–23. [Google Scholar] [CrossRef]
  48. Micoulaud-Franchi, J.A.; Lopez, R.; Vaillant, F.; Richieri, R.; El-Kaim, A.; Bioulac, S.; Philip, P.; Boyer, L.; Lancon, C. Perceptual abnormalities related to sensory gating deficit are core symptoms in adults with ADHD. Psychiatry Res. 2015, 230, 357–363. [Google Scholar] [CrossRef]
  49. Cervantes-Henríquez, M.L.; Acosta-López, J.E.; Martínez-Banfi, M.L.; Vélez, J.I.; Mejía-Segura, E.; Lozano-Gutiérrez, S.G.; Sánchez-Rojas, M.; Zurbarán, M.A.; Zurek, E.E.; Arcos-Burgos, M.; et al. ADHD Endophenotypes in Caribbean Families. J. Atten. Disord. 2018, 24, 2100–2114. [Google Scholar] [CrossRef] [Green Version]
  50. Villalón, J. Colonias Extranjeras En Barranquilla; Ediciones Uninorte: Barranquilla, Colombia, 2008. [Google Scholar]
  51. Mathias, R.A.; Taub, M.A.; Gignoux, C.R.; Fu, W.; Musharoff, S.; O’Connor, T.D.; Vergara, C.; Torgerson, D.G.; Pino-Yanes, M.; Shringarpure, S.S.; et al. A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome. Nat. Commun. 2016, 7, 1–10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Puentes-Rozo, P.J.; Acosta-Lopez, J.E.; Cervantes-Henriquez, M.L.; Martinez-Banfi, M.L.; Mejia-Segura, E.; Sanchez-Rojas, M.; Anaya-Romero, M.E.; Acosta-Hoyos, A.; García-Llinás, G.A.; Mastronardi, C.A.; et al. Genetic Variation Underpinning ADHD Risk in a Caribbean Community. Cells 2019, 8, 907. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Pineda, D.A.; Acosta, L.J.; Cervantes-Henríquez, M.L.; Jimenez-Figueroa, G.; Sánchez-Rojas, M.; Pineda-Alhucema, W.; Mejía-Segura, E.; Puentes-Rozo, J. Conglomerados de clases latentes en 408 miembros de 120 familias nucleares de Barranquilla con un caso índice afectado de trastorno de atención hiperactividad (TDAH). Acta Neurológica. Colomb. 2016, 32, 275–284. [Google Scholar] [CrossRef] [Green Version]
  54. Cervantes-Henríquez, M.L.; Acosta-López, J.; Aguirre-Acevedo, D.C.; Pineda-Álvarez, D.; Puentes Rozo, P. Fenotipo comportamental evaluado con una escala multidimensional de la conducta en niños y adolescentes de 30 familias con trastorno de atención-hiperactividad. Acta Neurol. Colomb. 2008, 24, 53–62. [Google Scholar]
  55. Ramírez, K.B.; Menco, A.V.; Torres, A. De Una Universidad Privada De La Ciudad De Barranquilla * Alcohol Use among Students in Third to Fifth Semester of Psychology Program At a Private. Psicogente 2014, 17, 460–476. [Google Scholar]
  56. Acosta-Lopez, J.; Cervantes-Henriquez, L.M.; Jiménez-Figueroa, G.; Nuñez Barragan, M.; Sanchez Rojas, M.; Puentes Rozo, P. Uso de una escala comportamental Wender Utah para evaluar en retrospectiva trastorno de atención-hiperactividad en adultos de la ciudad de Barranquilla. La Rev. Univ Y Salud. 2013, 15, 45–61. [Google Scholar]
  57. Reich, W. Diagnostic interview for children and adolescents (DICA). J. Am. Acad. Child Adolesc. Psychiatry 2000, 39, 59–66. [Google Scholar] [CrossRef] [Green Version]
  58. Arcos-Burgos, M.; Vélez, J.I.; Martinez, A.F.; Ribasés, M.; Ramos-Quiroga, J.A.; Sánchez-Mora, C.; Richarte, V.; Roncero, C.; Cormand, B.; Fernández-Castillo, N.; et al. ADGRL3 (LPHN3) variants predict substance use disorder. Transl. Psychiatry 2019, 9, 1–15. [Google Scholar] [CrossRef]
  59. Acosta, M.T.; Vélez, J.I.; Bustamante, M.L.; Balog, J.Z.; Arcos-Burgos, M.; Muenke, M. A two-locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long-term outcome. Transl. Psychiatry 2011, 1, 1–8. [Google Scholar] [CrossRef] [PubMed]
  60. Arcos-Burgos, M.; Jain, M.; Acosta, M.T.; Shively, S.; Stanescu, H.; Wallis, D.; Domené, S.; Vélez, J.I.; Karkera, J.D.; Balog, J.; et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol. Psychiatry 2010, 15, 1053–1066. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Wells, E.L.; Kofler, M.J.; Soto, E.F.; Schaefer, H.S.; Sarver, D.E. Assessing working memory in children with ADHD: Minor administration and scoring changes may improve digit span backward’s construct validity. Res. Dev. Disabil. 2018, 72, 166–178. [Google Scholar] [CrossRef]
  62. Kouvatsou, Z.; Masoura, E.; Kiosseoglou, G.; Kimiskidis, V.K. Working memory profiles of patients with multiple sclerosis: Where does the impairment lie? J. Clin. Exp. Neuropsychol. 2019, 41, 832–844. [Google Scholar] [CrossRef] [PubMed]
  63. Chrysochoou, E.; Bablekou, Z. Phonological loop and central executive contributions to oral comprehension skills of 5.5 to 9.5 years old children. Appl. Cogn. Psychol. 2011, 25, 576–583. [Google Scholar] [CrossRef]
  64. Baddeley, A.D.; Hitch, G. Working memory. In Psychology of Learning and Motivation; Elsevier: Amsterdam, The Netherlands, 1974; pp. 47–89. [Google Scholar]
  65. Baddeley, A.D.; Hitch, G.; Bower, G.H. The Psychology of Learning and Motivation; Academic Press: Cambridge, MA, USA, 1974. [Google Scholar]
  66. Tirapu-Ustarroz, J.; Luna-Lario, P. Neuropsicología de las funciones ejecutivas. Man. Neuropsicol. 2008, 2, 219–259. [Google Scholar]
  67. Tirapu-Ustárroz, J.; García-Molina, A.; Luna Lario, P.; Verdejo García, A.; Ríos Lago, M. Funciones ejecutivas y regulación de la conducta. Neuropsicol. La Corteza. Prefrontal. Y Las Funciones. Ejecutivas. 2012, 89–120. [Google Scholar]
  68. Trujillo, N.; Pineda, D. Función Ejecutiva en la investigación de los trastornos del comportamiento del niño y del adolescente. Rev. Neuropsicol. Neuropsiquiatría. Y Neurociencias. 2008, 8, 77–94. [Google Scholar]
  69. Spielman, R.S.; McGinnis, R.E.; Ewens, W.J. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 1993, 52, 506–516. [Google Scholar]
  70. Laird, N.M.; Horvath, S.; Xu, X. Implementing a unified approach to family-based tests of association. Genet. Epidemiol. 2000, 19 (Suppl. 1), S36–S42. [Google Scholar] [CrossRef]
  71. Xu, X.; Rakovski, C.; Xu, X.; Laird, N. An efficient family-based association test using multiple markers. Genet. Epidemiol. 2006, 30, 620–626. [Google Scholar] [CrossRef]
  72. Lange, C.; Laird, N.M. On a general class of conditional tests for family-based association studies in genetics: The asymptotic distribution, the conditional power, and optimality considerations. Genet. Epidemiol. 2002, 23, 165–180. [Google Scholar] [CrossRef] [PubMed]
  73. Lange, C.; Laird, N.M. Power calculations for a general class of family-based association tests: Dichotomous traits. Am. J. Hum. Genet. 2002, 71, 575–584. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Benjamini, Y.; Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B. 1995, 57, 289–300. [Google Scholar] [CrossRef]
  75. Vélez, J.I.; Correa, J.C.; Arcos-Burgos, M. A New Method for Detecting Significant p-values with Applications to Genetic Data. Rev. Colomb. Estadística. 2014, 37, 69–78. [Google Scholar] [CrossRef]
  76. Ramos-Quiroga, J.A.; Casas Brugue, M. Do we pay sufficient attention to the lack of care of hyperactivity in adults? Aten. Primaria. 2009, 41, 67–68. [Google Scholar] [CrossRef] [Green Version]
  77. Nikolaidis, A.; Gray, J.R. ADHD and the DRD4 exon III 7-repeat polymorphism: An international meta-analysis. Soc. Cogn. Affect. Neurosci. 2010, 5, 188–193. [Google Scholar] [CrossRef] [Green Version]
  78. Ramírez, L.E. La poblacion Afro en el departamento de Bolivar. Rev. Cult. Unilibre. 2012, 1, 53–58. [Google Scholar]
  79. Arcos-Burgos, M.; Castellanos, F.X.; Pineda, D.; Lopera, F.; Palacio, J.D.; Palacio, L.G.; Rapoport, J.L.; Berg, K.; Bailey-Wilson, J.E.; Muenke, M. Attention-deficit/hyperactivity disorder in a population isolate: Linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am. J. Hum. Genet. 2004, 75, 998–1014. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  80. Li, D.; Sham, P.C.; Owen, M.J.; He, L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum. Mol. Genet. 2006, 15, 2276–2284. [Google Scholar] [CrossRef]
  81. Banaschewski, T.; Becker, K.; Scherag, S.; Franke, B.; Coghill, D. Molecular genetics of attention-deficit/hyperactivity disorder: An overview. Eur. Child Adolesc. Psychiatry 2010, 19, 237–257. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Bolat, H.; Ercan, E.S.; Ünsel-Bolat, G.; Tahillioğlu, A.; Yazici, K.U.; Bacanli, A.; Pariltay, E.; Jafari, D.A.; Kosova, B.; Özgül, S.; et al. DRD4 genotyping may differentiate symptoms of attention-deficit/hyperactivity disorder and sluggish cognitive tempo. Braz. J. Psychiatry 2020, 42, 1–8. [Google Scholar] [CrossRef] [PubMed]
  83. Bruxel, E.M.; Salatino-Oliveira, A.; Akutagava-Martins, G.C.; Tovo-Rodrigues, L.; Genro, J.P.; Zeni, C.P.; Muenke, M. LPHN3 and attention-deficit/hyperactivity disorder: A susceptibility and pharmacogenetic study. Genes Brain Behav. 2015, 14, 419–427. [Google Scholar] [CrossRef] [Green Version]
  84. Swanson, J.M.; Flodman, P.; Kennedy, J.; Spence, M.A.; Moyzis, R.; Schuck, S.; Murias, M.; Moriarity, J.; Barr, C.; Smith, M.; et al. Dopamine genes and ADHD. Neurosci. Biobehav. Rev. 2000, 24, 21–25. [Google Scholar] [CrossRef]
  85. Swanson, J.M.; Sunohara, G.A.; Kennedy, J.L.; Regino, R.; Fineberg, E.; Wigal, T.; Lerner, M.; Williams, L.; LaHoste, G.J.; Wigal, S. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): A family-based approach. Mol. Psychiatry 1998, 3, 38–41. [Google Scholar] [CrossRef] [Green Version]
  86. Jain, M.; Velez, J.I.; Acosta, M.T.; Palacio, L.G.; Balog, J.; Roessler, E.; Pineda, D.; Londoño, A.C.; Palacio, J.D.; Arbelaez, A. A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD. Mol. Psychiatry 2012, 17, 741–747. [Google Scholar] [CrossRef] [Green Version]
  87. Arcos-Burgos, M.; Vélez, J.I.; Solomon, B.D.; Muenke, M. A common genetic network underlies substance use disorders and disruptive or externalizing disorders. Hum. Genet. 2012, 131, 917–929. [Google Scholar] [CrossRef] [Green Version]
  88. Blomquist, H.K. The role of the Child Health Services in the identification of children with possible attention deficit hyperactivity disorder/deficits in attention, motor control and perception (ADHD/DAMP). Acta Paediatr. Suppl. 2000, 89, 24–32. [Google Scholar] [CrossRef]
  89. Bruxel, E.M.; Moreira-Maia, C.R.; Akutagava-Martins, G.C.; Quinn, T.P.; Klein, M.; Franke, B.; Ribasés, M.; Rovira, P.; Sánchez-Mora, C.; Kappel, D.B.; et al. Meta-analysis and systematic review of ADGRL3 (LPHN3) polymorphisms in ADHD susceptibility. Mol. Psychiatry 2020, 1–9. [Google Scholar] [CrossRef] [PubMed]
  90. Huang, X.; Zhang, Q.; Gu, X.; Hou, Y.; Wang, M.; Chen, X.; Wu, J. LPHN3 gene variations and susceptibility to ADHD in Chinese Han population: A two-stage case-control association study and gene-environment interactions. Eur. Child Adolesc. Psychiatry 2019, 28, 861–873. [Google Scholar] [CrossRef] [PubMed]
  91. Martinez, A.F.; Abe, Y.; Hong, S.; Molyneux, K.; Yarnell, D.; Lohr, H.; Driever, W.; Acosta, M.T.; Arcos-Burgos, M.; Muenke, M. An Ultraconserved Brain-Specific Enhancer within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility. Biol. Psychiatry 2016, 80, 943–954. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  92. Domene, S.; Stanescu, H.; Wallis, D.; Tinloy, B.; Pineda, D.E.; Kleta, R.; Arcos-Burgos, M.; Roessler, E.; Muenke, M. Screening of human LPHN3 for variants with a potential impact on ADHD susceptibility. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2011, 156, 11–18. [Google Scholar] [CrossRef] [PubMed]
  93. Ribases, M.; Ramos-Quiroga, J.A.; Sanchez-Mora, C.; Bosch, R.; Richarte, V.; Palomar, G.; Gastaminza, X.; Bielsa, A.; Arcos-Burgos, M.; Muenke, M.; et al. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: A replication study. Genes Brain Behav. 2011, 10, 149–157. [Google Scholar] [CrossRef] [PubMed]
  94. Archer, T.; Oscar-Berman, M.; Blum, K. Epigenetics in Developmental Disorder: ADHD and Endophenotypes. J. Genet. Syndr. Gene Ther. 2011, 2, 1000104. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Rommelse, N.N.J. Endophenotypes in the genetic research of ADHD over the last decade: Have they lived up to their expectations? Expert Rev. Neurother. 2008, 8, 1425–1429. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Kane, M.J.; Engle, R.W. The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: An individual-differences perspective. Psychon. Bull. Rev. 2002, 9, 637–671. [Google Scholar] [CrossRef] [Green Version]
  97. Rajendran, K.; Rindskopf, D.; O’Neill, S.; Marks, D.J.; Nomura, Y.; Halperin, J.M. Neuropsychological functioning and severity of ADHD in early childhood: A four-year cross-lagged study. J. Abnorm. Psychol. 2013, 122, 1179–1188. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  98. Quinlan, P.T. Visual Feature Integration Theory: Past, Present, and Future. Psychol. Bull. 2003, 129, 643–673. [Google Scholar] [CrossRef] [Green Version]
  99. Loose, R.; Lutz, K.; Specht, K.; Shah, N.J.; Jancke, L. Cortical activations during paced finger-tapping applying visual and auditory pacing stimuli. Cogn. Brain Res. 2000, 10, 51–66. [Google Scholar]
  100. Toplak, M.E.; Tannock, R. Time perception: Modality and duration effects in attention-deficit/hyperactivity disorder (ADHD). J. Abnorm. Child Psychol. 2005, 33, 639–654. [Google Scholar] [CrossRef] [PubMed]
  101. Marshall, T.R.; O’Shea, J.; Jensen, O.; Bergmann, T.O. Frontal eye fields control attentional modulation of alpha and gamma oscillations in contralateral occipitoparietal cortex. J. Neurosci. 2015, 35, 1638–1647. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  102. Marshall, T.R.; Bergmann, T.O.; Jensen, O. Frontoparietal Structural Connectivity Mediates the Top-Down Control of Neuronal Synchronization Associated with Selective Attention. PLoS Biol. 2015, 13, e1002272. [Google Scholar] [CrossRef] [Green Version]
  103. Shang, C.Y.; Lin, H.Y.; Tseng, W.Y.; Gau, S.S. A haplotype of the dopamine transporter gene modulates regional homogeneity, gray matter volume, and visual memory in children with attention-deficit/hyperactivity disorder. Psychol. Med. 2018, 48, 2530–2540. [Google Scholar] [CrossRef] [Green Version]
  104. Sowell, E.R.; Thompson, P.M.; Welcome, S.E.; Henkenius, A.L.; Toga, A.W.; Peterson, B.S. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 2003, 362, 1699–1707. [Google Scholar] [CrossRef]
  105. Perchet, C.; Revol, O.; Fourneret, P.; Mauguière, F.; Garcia-Larrea, L. Attention shifts and anticipatory mechanisms in hyperactive children: An ERP study using the Posner paradigm. Biol. Psychiatry 2001, 50, 44–57. [Google Scholar] [CrossRef]
  106. Van der Stelt, O.; van der Molen, M.; Boudewijn, G.W.; Kok, A. Neuroelectrical signs of selective attention to color in boys with attention-deficit hyperactivity disorder. Brain Res. Cogn. Brain Res. 2001, 12, 245–264. [Google Scholar] [CrossRef]
  107. Johnson, K.A.; Dáibhis, A.; Tobin, C.T.; Acheson, R.; Watchorn, A.; Mulligan, A.; Barry, E.; Bradshaw, J.L.; Gill, M.; Robertson, I.H. Right-sided spatial difficulties in ADHD demonstrated in continuous movement control. Neuropsychologia 2010, 48, 1255–1264. [Google Scholar] [CrossRef]
  108. Rubia, K.; Smith, A.B.; Brammer, M.J.; Taylor, E. Temporal lobe dysfunction in medication-naïve boys with attention-deficit/hyperactivity disorder during attention allocation and its relation to response variability. Biol. Psychiatry 2007, 62, 999–1006. [Google Scholar] [CrossRef] [PubMed]
  109. Vance, A.; Silk, T.J.; Casey, M.; Rinehart, N.J.; Bradshaw, J.L.; Bellgrove, M.A.; Cunnington, R. Right parietal dysfunction in children with attention deficit hyperactivity disorder, combined type: A functional MRI study. Mol. Psychiatry 2007, 12, 826–832. [Google Scholar] [CrossRef] [Green Version]
  110. Mihali, A.; Young, A.G.; Adler, L.A.; Halassa, M.M.; Ma, W.J. A Low-Level Perceptual Correlate of Behavioral and Clinical Deficits in ADHD. Comput. Psychiatry 2018, 2, 141–163. [Google Scholar] [CrossRef]
  111. Solé, P.M.; Pérez, Z.L.; Puigcerver, L.; Esperalba, I.N.; Sanchez, G.C.; Romeo, A.; Crespillo, J.C.; Supèr, H. Attention-Related Eye Vergence Measured in Children with Attention Deficit Hyperactivity Disorder. PLoS ONE 2015, 10, e0145281. [Google Scholar]
  112. Guo, J.; Luo, X.; Wang, E.; Li, B.; Chang, Q.; Sun, L.; Song, Y. Abnormal alpha modulation in response to human eye gaze predicts inattention severity in children with ADHD. Dev. Cogn. Neurosci. 2019, 38, 100671. [Google Scholar] [CrossRef]
  113. Poltavski, D.V.; Biberdorf, D.; Petros, T.V. Accommodative response and cortical activity during sustained attention. Vision Res. 2012, 63, 1–8. [Google Scholar] [CrossRef] [Green Version]
  114. Crawford, S.G.; Kaplan, B.J.; Dewey, D. Effects of coexisting disorders on cognition and behavior in children with ADHD. J. Atten. Disord. 2006, 10, 192–199. [Google Scholar] [CrossRef]
  115. Caspersen, I.D.; Petersen, A.; Vangkilde, S.; Plessen, K.J.; Habekost, T. Perceptual and response-dependent profiles of attention in children with ADHD. Neuropsychology 2017, 31, 349–360. [Google Scholar] [CrossRef] [PubMed]
  116. Fuermaier, A.B.M.; Hupen, P.; De Vries, S.M.; Muller, M.; Kok, F.M.; Koerts, J.; Heutink, J.; Tucha, L.; Gerlach, M.; Tucha, O. Perception in attention deficit hyperactivity disorder. Atten. Defic. Hyperact. Disord. 2018, 10, 21–47. [Google Scholar] [CrossRef] [PubMed]
  117. Peskin, V.A.; Ordonez, A.; Mackin, R.S.; Delucchi, K.; Monge, S.; McGough, J.J.; Chavira, D.A.; Berrocal, M.; Cheung, E.; Fournier, E. Neuropsychological and dimensional behavioral trait profiles in Costa Rican ADHD sib pairs: Potential intermediate phenotypes for genetic studies. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2015, 168, 247–257. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  118. Bijlenga, D.; Tjon-Ka-Jie, J.Y.M.; Schuijers, F.; Kooij, J.J.S. Atypical sensory profiles as core features of adult ADHD, irrespective of autistic symptoms. Eur. Psychiatry 2017, 43, 51–57. [Google Scholar] [CrossRef]
  119. Burgess, N.; Maguire, E.A.; O’Keefe, J. The human hippocampus and spatial and episodic memory. Neuron 2002, 35, 625–641. [Google Scholar] [CrossRef] [Green Version]
  120. Crawford, S.G.; Dewey, D. Co-occurring disorders: A possible key to visual perceptual deficits in children with developmental coordination disorder? Hum. Mov. Sci. 2008, 27, 154–169. [Google Scholar] [CrossRef] [PubMed]
  121. Baddeley, A. Working memory: Theories, models, and controversies. Annu. Rev. Psychol. 2012, 63, 1–29. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  122. Fair, D.A.; Bathula, D.; Nikolas, M.A.; Nigg, J.T. Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD. Proc. Natl. Acad. Sci. USA 2012, 109, 6769–6774. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  123. Luo, Y.; Weibman, D.; Halperin, J.M.; Li, X. A review of heterogeneity in attention deficit/hyperactivity disorder (ADHD). Front. Hum. Neurosci. 2019, 13, 1–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  124. Acosta, M.T.; Arcos-Burgos, M.; Muenke, M. Attention deficit/hyperactivity disorder (ADHD): Complex phenotype, simple genotype? Genet. Med. 2004, 6, 1–15. [Google Scholar] [CrossRef] [Green Version]
  125. Pironti, V.A.; Lai, M.C.; Muller, U.; Dodds, C.M.; Suckling, J.; Bullmore, E.T.; Sahakian, B.J. Neuroanatomical abnormalities and cognitive impairments are shared by adults with attention-deficit/hyperactivity disorder and their unaffected first-degree relatives. Biol. Psychiatry 2014, 76, 639–647. [Google Scholar] [CrossRef] [Green Version]
  126. O’Malley, K.L.; Harmon, S.; Tang, L.; Todd, R.D. The rat dopamine D4 receptor: Sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol. 1992, 4, 137–146. [Google Scholar]
  127. Meador-Woodruff, J.H.; Grandy, D.K.; Van Tol, H.H.; Damask, S.P.; Little, K.Y.; Civelli, O.; Watson, S.J. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 1994, 10, 239–248. [Google Scholar] [CrossRef] [Green Version]
  128. Oak, J.N.; Oldenhof, J.; Van Tol, H.H. The dopamine D(4) receptor: One decade of research. Eur. J. Pharmacol. 2000, 405, 303–327. [Google Scholar] [CrossRef]
  129. Gehricke, J.-G.; Swanson, J.M.; Duong, S.; Nguyen, J.; Wigal, T.L.; Fallon, J.; Caburian, C.; Muftuler, L.T.; Moyzis, R.K. Increased brain activity to unpleasant stimuli in individuals with the 7R allele of the DRD4 gene. Psychiatry Res. 2015, 231, 58–63. [Google Scholar] [CrossRef] [Green Version]
  130. Faraone, S.V.; Biederman, J. Neurobiology of attention-deficit hyperactivity disorder. Biol. Psychiatry 1998, 44, 951–958. [Google Scholar] [CrossRef]
  131. Qian, A.; Tao, J.; Wang, X.; Liu, H.; Ji, L.; Yang, C.; Ye, Q.; Chen, C.; Li, J.; Cheng, C.; et al. Effects of the 2-repeat allele of the DRD4 gene on neural networks associated with the prefrontal cortex in children with ADHD. Front. Hum. Neurosci. 2018, 12, 1–12. [Google Scholar] [CrossRef] [PubMed]
  132. Rodríguez, M.Y.N.; Pola, A.L.; Juvier, R.T.; Cabal, R.R.; Soto, L.A.; Pérez García, E. Manifestaciones neuroftalmológicas en la enfermedad de Parkinson TT–Neurophthalmologic manifestations of Parkinson’s disease. Rev. Cuba Oftalmol. 2013, 26, 170–179. [Google Scholar]
  133. Müller, J.; Dreisbach, G.; Brocke, B.; Lesch, K.-P.; Strobel, A.; Goschke, T. Dopamine and cognitive control: The influence of spontaneous eyeblink rate, DRD4 exon III polymorphism and gender on flexibility in set-shifting. Brain Res. 2007, 1131, 155–162. [Google Scholar] [CrossRef]
  134. Beyer, C.; Banas, C.; Gonzalez-Flores, O.; Komisaruk, B.R. Blockage of substance P-induced scratching behavior in rats by the intrathecal administration of inhibitory amino acid agonists. Pharmacol. Biochem. Behav. 1989, 34, 491–495. [Google Scholar] [CrossRef]
  135. Saucedo, L.; Buffa, G.N.; Rosso, M.; Guillardoy, T.; Góngora, A.; Munuce, M.J.; Vazquez-Levin, M.H.; Marín-Briggiler, C. Fibroblast Growth Factor Receptors (FGFRs) in Human Sperm: Expression, Functionality and Involvement in Motility Regulation. PLoS ONE. 2015, 10, e0127297. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  136. Ford-Perriss, M.; Abud, H.; Murphy, M. Fibroblast growth factors in the developing central nervous system. Clin. Exp. Pharmacol. Physiol. 2001, 28, 493–503. [Google Scholar] [CrossRef]
  137. Itoh, N.; Ornitz, D.M. Fibroblast growth factors: From molecular evolution to roles in development, metabolism and disease. J. Biochem. 2011, 149, 121–130. [Google Scholar] [CrossRef] [Green Version]
  138. Dono, R. Fibroblast growth factors as regulators of central nervous system development and function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284, R867–R881. [Google Scholar] [CrossRef] [Green Version]
  139. Evans, S.J.; Choudary, P.V.; Neal, C.R.; Li, J.Z.; Vawter, M.P.; Tomita, H.; Lopez, J.F.; Thompson, R.C.; Meng, F.; Stead, J.D.; et al. Dysregulation of the fibroblast growth factor system in major depression. Proc. Natl. Acad. Sci. USA 2004, 101, 15506–15511. [Google Scholar] [CrossRef] [Green Version]
  140. Tekin, M.; Hişmi, B.O.; Fitoz, S.; Ozdağ, H.; Cengiz, F.B.; Sirmaci, A.; Aslan, İ.; İnceoğlu, B.; Yüksel-Konuk, E.B.; Yılmaz, S.T.; et al. Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia. Am. J. Hum. Genet. 2007, 80, 338–344. [Google Scholar] [CrossRef] [Green Version]
  141. Picker, A.; Brand, M. Fgf signals from a novel signaling center determine axial patterning of the prospective neural retina. Development 2005, 132, 4951–4962. [Google Scholar] [CrossRef] [Green Version]
  142. Yang, X.-J. Roles of cell-extrinsic growth factors in vertebrate eye pattern formation and retinogenesis. Semin. Cell. Dev. Biol. 2004, 15, 91–103. [Google Scholar] [CrossRef] [PubMed]
  143. Hyer, J.; Mima, T.; Mikawa, T. FGF1 patterns the optic vesicle by directing the placement of the neural retina domain. Development 1998, 125, 869–877. [Google Scholar] [CrossRef] [PubMed]
  144. Gabay, S.; Pertzov, Y.; Henik, A. Orienting of attention, pupil size, and the norepinephrine system. Atten. Percept. Psychophys. 2011, 73, 123–129. [Google Scholar] [CrossRef] [PubMed]
  145. Hwang, I.W.; Lim, M.H.; Kwon, H.J.; Jin, H.J. Association of LPHN3 rs6551665 A/G polymorphism with attention deficit and hyperactivity disorder in Korean children. Gene 2015, 566, 68–73. [Google Scholar] [CrossRef] [PubMed]
  146. Pronin, A.; Levay, K.; Velmeshev, D.; Faghihi, M.; Shestopalov, V.I.; Slepak, V.Z. Expression of olfactory signaling genes in the eye. PLoS ONE 2014, 9, e96435. [Google Scholar] [CrossRef] [PubMed]
  147. Fallgatter, A.J.; Ehlis, A.C.; Dresler, T.; Reif, A.; Jacob, C.P.; Arcos-Burgos, M.; Muenke, M.; Lesch, K.-P. Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD). Eur. Neuropsychopharmacol. 2013, 23, 458–468. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  148. Martinez, A.F.; Muenke, M.; Arcos-Burgos, M. From the black widow spider to human behavior: Latrophilins, a relatively unknown class of G protein-coupled receptors, are implicated in psychiatric disorders. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2011, 156, 1–10. [Google Scholar] [CrossRef] [Green Version]
  149. Mathiasen, S.; Palmisano, T.; Perry, N.A.; Stoveken, H.M.; Vizurraga, A.; McEwen, D.P.; Okashah, N.; Langenhan, T.; Inoue, A.; Lambert, N.A.; et al. G12/13 is activated by acute tethered agonist exposure in the adhesion GPCR ADGRL3. Nat. Chem. Biol. 2020, 16, 1343–1350. [Google Scholar] [CrossRef] [PubMed]
  150. Lange, M.; Norton, W.; Coolen, M.; Chaminade, M.; Merker, S.; Proft, F.; Schmitt, A.; Vernier, P.; Lesch, K.-P.; Bally-Cuif, L. The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Mol. Psychiatry 2012, 17, 946–954. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  151. Kesler, S.R.; Sheau, K.; Koovakkattu, D.; Reiss, A.L. Changes in frontal-parietal activation and math skills performance following adaptive number sense training: Preliminary results from a pilot study. Neuropsychol. Rehabil. 2011, 21, 433–454. [Google Scholar] [CrossRef] [PubMed]
  152. Arsalidou, M.; Pawliw-Levac, M.; Sadeghi, M.; Pascual-Leone, J. Brain areas associated with numbers and calculations in children: Meta-analyses of fMRI studies. Dev. Cogn. Neurosci. 2018, 30, 239–250. [Google Scholar] [CrossRef]
  153. Ansari, D.; Dhital, B. Age-related changes in the activation of the intraparietal sulcus during nonsymbolic magnitude processing: An event-related functional magnetic resonance imaging study. J. Cogn. Neurosci. 2006, 18, 1820–1828. [Google Scholar] [CrossRef]
  154. Serra-Grabulosa, J.M.; Adan, A.; Pérez-Pàmies, M.; Lachica, J.; Membrives, S. Neural bases of numerical processing and calculation. Rev. Neurol. 2010, 50, 39–46. [Google Scholar] [PubMed]
  155. Gruber, O.; Indefrey, P.; Steinmetz, H.; Kleinschmidt, A. Dissociating neural correlates of cognitive components in mental calculation. Cereb. Cortex. 2001, 11, 350–359. [Google Scholar] [CrossRef] [Green Version]
  156. Rickard, T.C.; Romero, S.G.; Basso, G.; Wharton, C.; Flitman, S.; Grafman, J. The calculating brain: An fMRI study. Neuropsychologia 2000, 38, 325–335. [Google Scholar] [CrossRef] [Green Version]
  157. Klein, E.; Moeller, K.; Glauche, V.; Weiller, C.; Willmes, K. Processing Pathways in Mental Arithmetic-Evidence from Probabilistic Fiber Tracking. PLoS ONE 2013, 8, e55455. [Google Scholar] [CrossRef] [Green Version]
  158. Sokolowski, H.M.; Fias, W.; Mousa, A.; Ansari, D. Common and distinct brain regions in both parietal and frontal cortex support symbolic and nonsymbolic number processing in humans: A functional neuroimaging meta-analysis. Neuroimage 2017, 146, 376–394. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  159. Nieder, A.; Dehaene, S. Representation of number in the brain. Annu. Rev. Neurosci. 2009, 32, 185–208. [Google Scholar] [CrossRef] [Green Version]
  160. Cowan, N. The magical number 4 in short-term memory: A reconsideration of mental storage capacity. Behav. Brain Sci. 2001, 24, 85–87. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  161. Geary, D.C.; Hoard, M.K.; Byrd-Craven, J.; DeSoto, M.C. Strategy choices in simple and complex addition: Contributions of working memory and counting knowledge for children with mathematical disability. J. Exp. Child Psychol. 2004, 88, 121–151. [Google Scholar] [CrossRef] [PubMed]
  162. Stanford, C.; Tannock, R. Behavioral Neuroscience of Attention Deficit Hyperactivity Disorder and Its Treatment; Springer: Berlin, Germany, 2012; Volume 2, pp. 1–554. [Google Scholar]
  163. Sebastián, M.V.; Mediavilla, R. Amplitud verbal de dígitos en orden directo en población española. Psicothema 2015, 27, 93–98. [Google Scholar]
  164. Lang, R.A. Pathways regulating lens induction in the mouse. Int. J. Dev. Biol. 2004, 48, 783–791. [Google Scholar] [CrossRef]
  165. Webber, C.A.; Hyakutake, M.T.; McFarlane, S. Fibroblast growth factors redirect retinal axons in vitro and in vivo. Dev. Biol. 2003, 263, 24–34. [Google Scholar] [CrossRef] [Green Version]
  166. Kinkl, N.; Ruiz, J.; Vecino, E.; Frasson, M.; Sahel, J.; Hicks, D. Possible involvement of a fibroblast growth factor 9 (FGF9)-FGF receptor-3-mediated pathway in adult pig retinal ganglion cell survival in vitro. Mol. Cell Neurosci. 2003, 23, 39–53. [Google Scholar] [CrossRef]
  167. Blanco, R.E.; López-Roca, A.; Soto, J.; Blagburn, J.M. Basic fibroblast growth factor applied to the optic nerve after injury increases long-term cell survival in the frog retina. J. Comp. Neurol. 2000, 423, 646–658. [Google Scholar] [CrossRef]
  168. Castellanos, F.X.; Proal, E. Large-scale brain systems in ADHD: Beyond the prefrontal-striatal model. Trends. Cogn. Sci. 2012, 16, 17–26. [Google Scholar] [CrossRef] [Green Version]
  169. Kravitz, D.J.; Saleem, K.S.; Baker, C.I.; Ungerleider, L.G.; Mishkin, M. The ventral visual pathway: An expanded neural framework for the processing of object quality. Trends. Cogn. Sci. 2013, 17, 26–49. [Google Scholar] [CrossRef] [Green Version]
  170. Ahrendts, J.; Rüsch, N.; Wilke, M.; Philipsen, A.; Eickhoff, S.B.; Glauche, V.; Perlov, E.; Ebert, D.; Hennig, J.; van Elst, L.T. Visual cortex abnormalities in adults with ADHD: A structural MRI study. World J. Biol. Psychiatry Off. J. World Fed. Soc. Biol. Psychiatry 2011, 12, 260–270. [Google Scholar] [CrossRef]
  171. Wang, L.; Zhu, C.; He, Y.; Zang, Y.; Cao, Q.; Zhang, H.; Zhong, Q.; Wang, Y. Altered small-world brain functional networks in children with attention-deficit/hyperactivity disorder. Hum. Brain Mapp. 2009, 30, 638–649. [Google Scholar] [CrossRef] [PubMed]
  172. Silk, T.J.; Vance, A.; Rinehart, N.; Bradshaw, J.L.; Cunnington, R. Dysfunction in the Fronto-Parietal Network in Attention Deficit Hyperactivity Disorder (ADHD): An fMRI Study. Brain Imaging Behav. 2008, 2, 123–131. [Google Scholar] [CrossRef]
  173. Wechsler, D. WISC-V: Technical and Interpretive Manual, 5th ed.; Pearson Clinical Assessment, PsychCorp: London, UK, 2012; Volume 2. [Google Scholar]
  174. Fang, F.; Kersten, D.; Murray, S.O. Perceptual grouping and inverse fMRI activity patterns in human visual cortex. J. Vis. 2008, 8, 2. [Google Scholar] [CrossRef] [PubMed]
  175. Aboitz, F.; Castellanos, F. Attention deficit hyperactivity disorder, catecholamines, and the default mode of brain function: A reassessment of the dopaminergic hypothesis of ADHD. In Treating Attention Deficit Hyperactivity Disorder; Civic Research Institute Kingston: Princeton, NJ, USA, 2011; pp. 1–2. [Google Scholar]
  176. Hupé, J.-M.; Pressnitzer, D. The initial phase of auditory and visual scene analysis. Philos. Trans. R. Soc. London Ser. B Biol. Sci. 2012, 367, 942–953. [Google Scholar] [CrossRef]
  177. Knapen, T.; Brascamp, J.; Adams, W.J.; Graf, E.W. The spatial scale of perceptual memory in ambiguous figure perception. J. Vis. 2009, 9, 16. [Google Scholar] [CrossRef] [Green Version]
  178. Roelfsema, P.R.; Tolboom, M.; Khayat, P.S. Different processing phases for features, figures, and selective attention in the primary visual cortex. Neuron 2007, 56, 785–792. [Google Scholar] [CrossRef] [Green Version]
  179. Nigg, J.T.; Casey, B.J. An integrative theory of attention-deficit/hyperactivity disorder based on the cognitive and affective neurosciences. Dev. Psychopathol. 2005, 17, 785–806. [Google Scholar] [CrossRef]
  180. Sarkar, I.N. Biomedical informatics and translational medicine. J. Transl. Med. 2010, 8, 22. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  181. Kalow, W. Pharmacogenetics and pharmacogenomics: Origin, status, and the hope for personalized medicine. Pharm. J. 2006, 6, 162–165. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  182. Tenev, A.; Markovska-Simoska, S.; Kocarev, L.; Pop-Jordanov, J.; Müller, A.; Candrian, G. Machine learning approach for classification of ADHD adults. Int. J. Psychophysiol. 2014, 93, 162–166. [Google Scholar] [CrossRef]
  183. Kautzky, A.; Vanicek, T.; Philippe, C.; Kranz, G.S.; Wadsak, W.; Mitterhauser, M.; Hartmann, A.; Hahn, A.; Hacker, M.; Rujescu, D.; et al. Machine learning classification of ADHD and HC by multimodal serotonergic data. Transl. Psychiatry 2020, 10, 1–9. [Google Scholar] [CrossRef] [Green Version]
  184. Vélez, J.I. Machine Learning based Psychology: Advocating for A Data-Driven Approach. Int. J. Psychol. Res. 2021, 14, 6–11. [Google Scholar] [CrossRef]
  185. Owens, J.; Jackson, H. Attention-deficit/hyperactivity disorder severity, diagnosis, & later academic achievement in a national sample. Soc. Sci. Res. 2017, 61, 251–265. [Google Scholar] [PubMed] [Green Version]
Table 1. ADHD cognitive endophenotypes in 408 individuals belonging to 113 nuclear families from Barranquilla, Colombia.
Table 1. ADHD cognitive endophenotypes in 408 individuals belonging to 113 nuclear families from Barranquilla, Colombia.
Coding aTaskAffected
(n = 236)
Unaffected
(n = 172)
dPHeritability
h2 (SE)p
Mental ControlMean (SD)Mean (SD)
T4Numbers from 20 to 1 (Score)2.13 (0.99)2.55 (0.7)−0.4830.0340.351 (0.138)0.006
Semantic Verbal Fluency
T32Token Test 36/3631.36 (3.8)33.51 (2.68)−0.6370.0010.355 (0.124)0.002
WISC-III and WAIS-III subtests
T42Digit span total—Forward6.84 (1.73)7.8 (1.92)−0.5263.7 × 10−40.492 (0.107)1.0 × 10−5
T43Digit span total—Backward4.53 (1.88)5.24 (1.87)−0.3750.0010.171 (0.102)0.048
T44Total punctuation (forward and backward)11.32 (3.06)13.12 (3.33)−0.5641.6 × 10−50.416 (0.109)6.8 × 10−5
T45Vocabulary28.28 (10.63)35.51 (10.99)−0.6700.0050.452 (0.126)1.7 × 10−4
T46Comprehension17.75 (6.27)21.01 (5.88)−0.5330.0190.210 (0.107)0.025
T47Arithmetic12.94 (4.52)12.87 (3.87)0.0160.0070.365 (0.116)0.001
T48Similarities (analogies)16.16 (6.98)20.55 (5.89)−0.6710.0020.366 (0.130)0.003
T49Figure completion18.81 (4.86)20.58 (3.45)−0.4100.0360.235 (0.133)0.039
T52Object assembly25.56 (8.8)29.92 (9.13)−0.4880.0120.323 (0.132)0.007
a Refers to clinical variables/tasks in Cervantes-Henriquez et al. [49]. d = Cohen’s effect size; h2 = heritability estimated value. p-values < 0.05 are shown in bold. WISC-III = Wechsler Intelligence Scale for Children, 3rd edition; WAIS-III = Wechsler Adult Intelligence Scale, 3rd edition. A Logistic Regression for predicting ADHD diagnosis using these endophenotypes of working memory and perceptual organization led to an accuracy of 73% (95%CI = 68.4–77.2). Modified from Cervantes-Henriquez et al. [49].
Table 2. Results of the FBAT on ADHD endophenotypes in 113 nuclear families from an African-descent community.
Table 2. Results of the FBAT on ADHD endophenotypes in 113 nuclear families from an African-descent community.
Coding aChrMarkerGenePosition bFBAT Results
AlleleCohortPFBAT (NIF)
FrequencyAdditiveDominantRecessiveHA
T4411rs916457DRD4637,014T0.0500.026 (27)0.025 (27)
C0.950 0.025 (27)
T464rs10001410ADGRL362,474,229A0.327 0.047 (54)
C0.673 0.047 (54)
T474rs1565902ADGRL362,408,620C0.4950.014 (65)
T0.5050.014 (65)
5rs2282794FGF1141,981,709G0.542 0.041 (32)
A0.458 0.041 (32)
T485rs2282794FGF1141,981,709G0.5420.004 (64) 1.9 × 10−4 (32)
A0.4580.004 (64) 1.9 × 10−4 (32)
T4911rs916457DRD4637,014C0.9500.005 (27) 0.005 (27)
T0.0500.005 (27) 0.005 (27)
5rs2282794FGF1141,981,709G0.542 0.006 (32)
A0.458 0.006 (32)
T525rs2282794FGF1141,981,709G0.542 0.005 (64)
A0.458 0.005 (64)
a Refers to subtests of the Wechsler Intelligence Scale for Children, 3rd Edition (WISC-III), and the Wechsler Adult Intelligence Scale, 3rd Edition (WAIS-III) batteries used Cervantes-Henriquez et al. [49]. T44: Total punctuation of the digit span (forward and backward); T46: Comprehension; T47: Arithmetic; T48: Similarities (analogies); T49: Figure completion and T52: Object assembly. See Table 1 for more details. b UCSC GRCh37/hg19 coordinates. Chr: Chromosome; HA: Heterozygous advantage; NIF: Number of informative families; FBAT: Family-based association test; PFBAT: p-value from the FBAT. For interpretation purposes, p-values in bold are statistically significant at 5% after correction for multiple testing using Bonferroni’s method.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Cervantes-Henriquez, M.L.; Acosta-López, J.E.; Ahmad, M.; Sánchez-Rojas, M.; Jiménez-Figueroa, G.; Pineda-Alhucema, W.; Martinez-Banfi, M.L.; Noguera-Machacón, L.M.; Mejía-Segura, E.; De La Hoz, M.; et al. ADGRL3, FGF1 and DRD4: Linkage and Association with Working Memory and Perceptual Organization Candidate Endophenotypes in ADHD. Brain Sci. 2021, 11, 854. https://0-doi-org.brum.beds.ac.uk/10.3390/brainsci11070854

AMA Style

Cervantes-Henriquez ML, Acosta-López JE, Ahmad M, Sánchez-Rojas M, Jiménez-Figueroa G, Pineda-Alhucema W, Martinez-Banfi ML, Noguera-Machacón LM, Mejía-Segura E, De La Hoz M, et al. ADGRL3, FGF1 and DRD4: Linkage and Association with Working Memory and Perceptual Organization Candidate Endophenotypes in ADHD. Brain Sciences. 2021; 11(7):854. https://0-doi-org.brum.beds.ac.uk/10.3390/brainsci11070854

Chicago/Turabian Style

Cervantes-Henriquez, Martha L., Johan E. Acosta-López, Mostapha Ahmad, Manuel Sánchez-Rojas, Giomar Jiménez-Figueroa, Wilmar Pineda-Alhucema, Martha L. Martinez-Banfi, Luz M. Noguera-Machacón, Elsy Mejía-Segura, Moisés De La Hoz, and et al. 2021. "ADGRL3, FGF1 and DRD4: Linkage and Association with Working Memory and Perceptual Organization Candidate Endophenotypes in ADHD" Brain Sciences 11, no. 7: 854. https://0-doi-org.brum.beds.ac.uk/10.3390/brainsci11070854

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop